
Kenya Secures $407 Million Global Fund For Human Immunodeficiency Virus (HIV), Tuberculosis (TB) And Malaria
Download logo
Kenya and the Global Fund have signed a $407,887,067 grant to combat HIV, TB, and malaria.
Previous grants have led to significant achievements, including a drop in malaria prevalence from 8% in 2015 to 6% in 2023 through mass distribution of mosquito nets and prompt treatment measures. The TB program has successfully treated over 85% of 264,856 patients, incorporating innovations like AI-enhanced screening and community-based services.
Speaking
during the grant signing
in Nairobi, Principal Secretary State Department for Public Health and Professional Standards Mary Muthoni reiterated government's commitment to build on the gains through partnerships
and community based innovative approaches.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Bitmex Launches Market May-Hem Trading Competition With A 310,000 USDT Prize Pool
- Bitget Launches PUNDIXUSDT Perpetual Futures And Enables Trading Bots
- Shardeum Mainnet Goes Live, Debuting Autoscaling L1 After Record Testnet Validator Participation
- Pepeto To Launch On Exchange Following Presale Wrap-Up And Platform Milestones
- Global Financial Crime Prevention Leader Feedzai Acquires Demyst To Break Down Data Silos And Accelerate Risk Decisions
- Bydfi Partners With Ledger To Launch Limited Edition Hardware Wallet, Debuts At TOKEN2049 Dubai
Comments
No comment